Senolytic Stacking: The Ultimate Combination Protocol Guide
Expert Summary
Different senescent cell types express different anti-apoptotic survival proteins. Adipose senescent cells rely on BCL-2; epithelial senescent cells rely on src kinase; muscle senescent cells rely on BCL-W and BCL-XL. A comprehensive senolytic stack covers these distinct survival pathways through complementary agents.
Key Facts
- Coverage map: Fisetin → BCL-W/BCL-XL (muscle, brain, fat), Quercetin → BCL-2/BCL-XL (adipose, vascular), Dasatinib → src/ephrin (epithelial, preadipocytes), Spermidine → autophagy (all cell types prevention).
- Tier 1 (natural, OTC): Daily spermidine (2–4 mg) + monthly fisetin burst (20 mg/kg × 2 days) + quercetin phytosome (200 mg/day continuous, 1,000 mg on burst days).
- Tier 2 (physician-supervised): Add dasatinib (100 mg × 2 days quarterly) to Tier 1. Broadest senolytic coverage available.
- Synergy vs competition: Fisetin and quercetin are synergistic (different BCL-2 family members). Quercetin and dasatinib are specifically designed as a combination. Spermidine is additive with all senolytics via autophagy activation.
- Stacking timing: Spermidine and low-dose quercetin: daily continuous. Fisetin burst + high-dose quercetin: 2 days/month. Dasatinib: 2 days/quarter (if using).
- Monitor with biomarkers: Track hsCRP, IL-6, and ferritin before and after each senolytic cycle to assess effectiveness.
Recommended Products
Frequently Asked Questions
Should I start all agents simultaneously?
No. Start with one agent (fisetin or quercetin), evaluate tolerance for 1–2 cycles, then layer in additional agents. This allows attribution of any effects or side effects.
Is there a maximum number of senolytics I can combine?
No hard limit, but practical complexity increases with each addition. Three agents (fisetin + quercetin + spermidine) covers most mechanisms efficiently. Adding a fourth (dasatinib) requires physician oversight.
How long before I feel the effects of a senolytic stack?
Subjective energy, inflammation, and recovery improvements are often noticed within 1–3 cycles (months). Measurable biomarker improvements typically require 3–6 months.
Scientific References
- Xu M et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018. PMID: 29988130
- Kirkland JL et al. The clinical potential of senolytic drugs. Journal of the American Geriatrics Society. 2017. PMID: 28869295